![](https://endpts.com/wp-content/uploads/2023/03/Mathai-Mammen-Fog-Pharma-feature.jpg)
Mathai Mammen, FogPharma CEO
FogPharma bags $145M, adds Alexis Borisy to the board
FogPharma, a biotech from Harvard researcher Greg Verdine that is led by former Johnson & Johnson R&D leader
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.